These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3919422)

  • 1. Central noradrenergic neurons and the hypertensive effects of intracerebroventricularly administered prostaglandin E2 in anaesthetized rabbits.
    Otorii T; Ohkubo K; Suzuki K
    Prostaglandins; 1985 Jan; 29(1):25-33. PubMed ID: 3919422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of the sympathetic nervous system in the centrogenic pressor and tachycardiac effects of prostaglandins E2 and F2 alpha in anaesthetised cats.
    Rao TS; Seth SD; Manchanda SC; Nayar U
    Brain Res; 1987 Dec; 435(1-2):7-14. PubMed ID: 2827859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of putative neurotransmitters in the central gastric antisecretory effect of prostaglandin E2 in rats.
    Puurunen J
    Br J Pharmacol; 1985 May; 85(1):213-21. PubMed ID: 2862940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 6-hydroxydopamine and some hypotensive drugs on lypressin induced hypertension in rats.
    Szadowska A; Szmigielska H; Szmigielski A; Kamińska A; Wejman I
    Pol J Pharmacol Pharm; 1985; 37(4):487-93. PubMed ID: 3936030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented central cholinergic mechanisms in spontaneously hypertensive rats. Involvement of deranged noradrenergic mechanisms in the brain.
    Takahashi H; Inoue A; Takeda K; Okajima H; Sasaki S; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Heart J; 1984 May; 25(3):397-410. PubMed ID: 6088825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central noradrenergic mechanisms and the cardiovascular effects of intracerebroventricular (+)- and (-)-propranolol in the conscious rabbit.
    Myers MG; Lewis PJ; Reid JL; Dollery CT
    Neuropharmacology; 1975 Mar; 14(3):221-6. PubMed ID: 1134627
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypothalamic alpha-adrenergic blockade modifies drinking and blood pressure responses to central angiotensin II in conscious rats.
    Jones DL
    Can J Physiol Pharmacol; 1988 Oct; 66(10):1270-7. PubMed ID: 2907299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central angiotensin II and PGE2 act independently to increase blood pressure in conscious sheep.
    Breuhaus BA; Chimoskey JE
    Am J Physiol; 1987 Jan; 252(1 Pt 2):R73-7. PubMed ID: 3468805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hypertensive effects of propranolol unaltered by 6-hydroxydopamine given intraventricularly to SHR.
    Kubo T; Misu Y
    Jpn J Pharmacol; 1981 Apr; 31(2):286-8. PubMed ID: 6273626
    [No Abstract]   [Full Text] [Related]  

  • 10. Sympathoadrenomedullary system mediation of the prostaglandin E2-induced central inhibition of gastric acid output in rats.
    Yokotani K; Yokotani K; Okuma Y; Osumi Y
    J Pharmacol Exp Ther; 1988 Jan; 244(1):335-40. PubMed ID: 3422095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and antidiuretic effects of central prostaglandin E2.
    Hoffman WE; Schmid PG
    J Physiol; 1979 Mar; 288():159-69. PubMed ID: 469713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrally-induced vasodepressor responses to diltiazem, a calcium channel blocker, in rats.
    Iyoda I; Takahashi H; Takeda K; Inoue A; Yoneda S; Sasaki S; Okajima H; Yoshimura M; Ijichi H
    J Hypertens; 1985 Dec; 3(6):639-44. PubMed ID: 3866796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular role of the major noradrenergic cell groups in the rabbit: analysis based on 6-hydroxydopamine-induced transmitter release.
    Korner PI; Badoer E; Head GA
    Brain Res; 1987 Dec; 435(1-2):258-72. PubMed ID: 2892575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Central hypotensive effects of guanfacine in anaesthetised rabbits (author's transl)].
    Ohkubo K; Suzuki K; Oguma M; Otorii T
    Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):263-74. PubMed ID: 7047324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular responses produced by the injection of dopamine into the cerebral ventricles of the unanaesthetized dog.
    Lang WJ; Woodman OL
    Br J Pharmacol; 1979 Jun; 66(2):235-40. PubMed ID: 465876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intracerebroventricular prostaglandins E2 and F2alpha on the urine outflow, and a possible role of pgE2 as a modulator.
    Fujimoto S; Hisada S
    Jpn J Pharmacol; 1978 Feb; 28(1):33-40. PubMed ID: 651014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and heart rate effects of prostaglandin E2 and F2 alpha produced by intracerebroventricular injections in cats.
    Gillis RA; Quest JA; Souza JD; Kot PA; Ramwell PW
    Prostaglandins; 1981 Dec; 22(6):1003-12. PubMed ID: 6950459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of hypertension: participation of central adrenaergic mechanism on the angiotensin II-induced hypertension.
    Iijima M; Yamamoto N; Kitamura Y; Yasugi T; Hatano M
    Jpn Circ J; 1977 Mar; 41(3):267-79. PubMed ID: 859212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gastric acid secretion by intracerebroventricularly administered prostaglandin e2 in anaesthetized rats.
    Puurunen J
    Br J Pharmacol; 1983 Jan; 78(1):131-5. PubMed ID: 6337659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of central noradrenergic neurons in arterial baroreceptor reflexes in the rabbit. A study with intracisternally administered 6-hydroxydopamine.
    Chalmers JP; Reid JL
    Circ Res; 1972 Nov; 31(5):789-804. PubMed ID: 5084886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.